Northwell to Launch Long Island’s First Pancreas Transplant
Northwell Transplant Institute is one of 59 adult transplant centers in the U.S. to offer heart, kidney, liver, lung and pancreas programs Northwell Health has received...
Category : Healthcare and Pharmaceutical
Hope Biosciences Reports Promising Phase II Parkinson’s Trial
Houston-area clinical research organization Hope Biosciences Research Foundation (HBRF) today shares positive top-line results of a Phase II clinical trial to evaluate Hope Biosciences’ allogeneic adipose‑derived mesenchymal...
Celltrion Gets Positive CHMP Opinion for SteQeyma™ Autoinjector
Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion...
Mondego Bio Selects PTPN2 Inhibitor, Targets First Trials in 2026
Mondego Bio, a clinical-stage biotechnology company developing next-generation small-molecule immuno-oncology therapies, today announced the formal selection of its lead clinical candidate, ZE00-0388, a highly selective...
Menarini announces CELLSEARCH® CTC biomarker analysis results
The secondary analysis of the PACE trial highlights the value of counting Circulating Tumor Cells (CTCs) in the blood to help guide treatment escalation or...
AusperBio Completes Phase III AUSHINE Study Patient Enrollment
AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (together AusperBio), a clinical-stage biotechnology company developing targeted oligonucleotide therapies for functional cure of chronic hepatitis B (CHB), today announced the completion...
Samsung Biologics expands U.S. manufacturing with GSK acquisition
Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), today announced that its wholly owned U.S. subsidiary, Samsung Biologics America, has entered...
Syremis Therapeutics Raises $165M for Mental Health Drugs
Addressing major unmet needs in mental health with pharmacology rooted in emerging and clinically validated neuropsychiatric biology Lead program ST-905, a potent M1/M4 muscarinic agonist,...
AtomVie Secures Supply Deal with Ionetix for Ac-225 Drugs
AtomVie Global Radiopharma (AtomVie), a global radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) specializing in GMP manufacturing and clinical supply, is pleased to announce a...
CISCRP Launches Interactive Dashboard for Clinical Research
The Center for Information and Study on Clinical Research Participation (CISCRP) has launched an interactive data dashboard, giving clinical research stakeholders customized access to data...
Attune Supports Poppy Health’s $38M ARPA-H BREATHE Project
Attune announced today that the company will play a supporting role in the ARPA-H BREATHE program, leveraging Attune’s industry-leading IoT sensor-based technology for air quality...
PharmAla Biotech Contracts UK CDMO for ALA-002 Production
PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class...
DATROWAY® EU Approval for Metastatic TNBC Treatment
Based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only medicine to significantly improve overall survival versus...
PureTech Names Robert Lyne as CEO
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value,...
Takeda’s Zasocitinib Phase 3 Data Shows Clear Skin Results
Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half of...